HLB Life Science Co., Ltd. (KOSDAQ: 067630)
South Korea
· Delayed Price · Currency is KRW
9,360.00
-990.00 (-9.57%)
Oct 11, 2024, 9:00 AM KST
HLB Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,110,529 | 1,165,599 | 1,077,864 | 1,188,951 | 1,280,316 | 1,305,844 | |
Market Cap Growth | -14.37% | 8.14% | -9.34% | -7.14% | -1.95% | 109.16% | |
Enterprise Value | 1,158,607 | 1,260,366 | 1,030,778 | 1,020,209 | 1,153,412 | 1,255,129 | |
Last Close Price | 9360.00 | 11155.39 | 10327.26 | 11533.40 | 12598.74 | 12853.49 | |
PE Ratio | - | -189.76 | -19.21 | -23.31 | -22.34 | -157.19 | |
PS Ratio | 10.64 | 11.90 | 10.82 | 22.23 | 13.95 | 11.45 | |
PB Ratio | 3.09 | 5.04 | 4.57 | 4.82 | 4.45 | 3.90 | |
P/FCF Ratio | -15.92 | -38.05 | -26.67 | -72.04 | -200.05 | -60.84 | |
P/OCF Ratio | -31.48 | -116.37 | -36.24 | -84.42 | 636.96 | -105.41 | |
EV/Sales Ratio | 12.48 | 12.86 | 10.35 | 19.07 | 12.56 | 11.01 | |
EV/EBITDA Ratio | -42.38 | -70.82 | -69.99 | -64.39 | -200.14 | -361.16 | |
EV/EBIT Ratio | -32.12 | -49.44 | -51.67 | -55.66 | -143.86 | -233.43 | |
EV/FCF Ratio | -20.84 | -41.14 | -25.50 | -61.81 | -180.22 | -58.47 | |
Debt / Equity Ratio | 0.33 | 0.72 | 0.62 | 0.02 | 0.04 | 0.04 | |
Debt / FCF Ratio | -2.15 | -5.44 | -3.65 | -0.28 | -1.78 | -0.56 | |
Asset Turnover | 0.20 | 0.23 | 0.29 | 0.18 | 0.25 | 0.29 | |
Inventory Turnover | 16.27 | 12.26 | 16.27 | 30.72 | 19.42 | 16.40 | |
Quick Ratio | 1.31 | 0.68 | 5.49 | 11.28 | 9.85 | 5.42 | |
Current Ratio | 1.41 | 0.73 | 6.00 | 11.59 | 10.15 | 5.61 | |
Return on Equity (ROE) | -3.06% | -2.53% | -22.52% | -18.45% | -17.95% | -2.80% | |
Return on Assets (ROA) | -3.85% | -3.81% | -3.65% | -3.83% | -1.37% | -0.87% | |
Return on Capital (ROIC) | -4.00% | -4.08% | -3.93% | -4.16% | -1.55% | -1.04% | |
Earnings Yield | -0.93% | -0.51% | -5.04% | -4.13% | -4.36% | -0.58% | |
FCF Yield | -5.01% | -2.63% | -3.75% | -1.39% | -0.50% | -1.64% | |
Buyback Yield / Dilution | -0.69% | -0.80% | -1.64% | -0.34% | -6.39% | -54.49% | |
Total Shareholder Return | -0.69% | -0.80% | -1.64% | -0.34% | -6.39% | -54.49% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.